Global Dry Eye Syndrome Treatment Market - Industry Trends and Forecast to 2026
Short Description
By Product Type (Emulsions, Lubricant Eye Drops/Solutions, Eye Ointments, Autologous Serum Eye Drops, Nutrition Supplements, Others), Disease Type (Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome), Treatment Type (Lubricating Agents, Tear Stimulators, Artificial Tears, Anti-Inflammatory Drugs, Antibiotic Drugs, Others), End User (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Market Definition:
Dry eye syndrome is a multifactorial disease of the ocular surface and tears which results in the symptoms of visual disturbance, tear film instability and discomfort with potential damage of the ocular surface. Dry eye happens when the eyes do not produce the tears properly, or when the consistency of the tears is not correct and evaporates too quickly.
Dry eye syndrome is the chronic condition which is categorized into:
• Evaporative dry eye (EDE) – It is the most common type of dry eye syndrome which is often related with an unstable tear film and the increased evaporation. Meibomian gland dysfunction (MGD) is considered as the leading cause of evaporative dry eye.
• Aqueous tear-deficient dry eye (ADDE) – It refers mainly to a failure of the lacrimal tear secretion.
Market Segmentation:
Global dry eye syndrome treatment market is segmented into five notable segments which are product type, disease type, treatment type, end user and distribution channel.
• On the basis of product type, the market is segmented into emulsions, lubricant eye drops/solutions, eye ointments, nutrition supplements, autologous serum eye drops and others
• On the basis of disease type, the market is segmented into evaporative dry eye syndrome and aqueous dry eye syndrome
• On the basis of treatment type, the market is segmented into tear stimulators, lubricating agents, anti-inflammatory drugs, artificial tears, antibiotic drugs and others
• On the basis end user, the market is segmented into of home healthcare, hospitals, clinics and others
• On the basis of distribution channel, the market is segmented into of hospital pharmacies, retail pharmacies, online pharmacies and others
Market Players
The key market players are listed below:
• Mitotech, SA
• Johnson & Johnson Services, Inc.
• Sun Pharmaceutical Industries Ltd.
• ALLERGAN
• Novaliq GmbH
• Prestige Consumer Healthcare, Inc.
• Horus Pharma
• Senju Pharmaceutical Co. Ltd.
• VISUfarma
• Akorn, Incorporated
• Bausch & Lomb Incorporated
• Teva Pharmaceutical Industries Ltd.
• Alcon Inc.
• Santen Pharmaceutical Co., Ltd.
• Novartis AG
• Similasan
• Others
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Global Dry Eye Syndrome Treatment Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Global Dry Eye Syndrome Treatment Market: Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Primary Interviews With Key Opinion Leaders
- 2.7 Dbmr Market Position Grid
- 2.8 Dbmr Vendor Share Analysis
- 2.9 Multivariate Modeling
- 2.10 Products Lifeline Curve
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Market Overview
- 3.1 Drivers
- 3.1.1 Increasing Prevalence Of Dry Eye Diseases
- 3.1.2 Changing Geographical Trends To Drive The Market
- 3.1.3 Increasing Awareness About Diagnosis And Treatment Of The Disease
- 3.1.4 Rising Geriatric Population Across The World
- 3.1.5 Increase In Lasik Surgery And Usage Of Contact Lenses
- 3.2 Restraints
- 3.2.1 Stringent Regulatory Process
- 3.2.2 Unmet Medical Needs
- 3.3 Opportunities
- 3.3.1 Emerging Market Presents Significant Opportunities
- 3.3.2 Development Of Novel Technologies
- 3.4 Challenge
- 3.4.1 Increasing Number Of Players
- 4 Executive Summary
- 5 Premium Insights
- 6 Global Dry Eye Syndrome Treatment Market, By Product Type
- 6.1 Overview
- 6.2 Emulsions
- 6.3 Lubricant Eye Drops/Solutions
- 6.3.1 Oily Tear Eye Drop
- 6.3.2 Preservative-free Drops
- 6.4 Eye Ointments
- 6.5 Nutrition Supplements
- 6.6 Autologous Serum Eye Drops
- 6.7 Others
- 7 Global Dry Eye Syndrome Treatment Market, By Disease Type
- 7.1 Overview
- 7.2 Evaporative Dry Eye Syndrome
- 7.3 Aqueous Dry Eye Syndrome
- 8 Global Dry Eye Syndrome Treatment Market, By Treatment Type
- 8.1 Overview
- 8.2 Tear Stimulators
- 8.3 Lubricating Agents
- 8.4 Anti-inflammatory Drugs
- 8.5 Artificial Tears
- 8.6 Antibiotic Drugs
- 8.7 Others
- 9 Global Dry Eye Syndrome Treatment Market, By End User
- 9.1 Overview
- 9.2 Home Healthcare
- 9.3 Hospitals
- 9.4 Clinics
- 9.5 Others
- 10 Global Dry Eye Syndrome Treatmentmarket, By Distribution Channel
- 10.1 Overview
- 10.2 Retail Pharmacies
- 10.3 Hospital Pharmacies
- 10.4 Online Pharmacies
- 10.5 Others
- 11 Global Dry Eye Syndrome Treatment Market, By Geography
- 11.1 Overview
- 11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 U.K.
- 11.3.3 France
- 11.3.4 Italy
- 11.3.5 Spain
- 11.3.6 Russia
- 11.3.7 Netherlands
- 11.3.8 Switzerland
- 11.3.9 Belgium
- 11.3.10 Turkey
- 11.3.11 Rest Of Europe
- 11.4 Asia-pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 South Korea
- 11.4.4 India
- 11.4.5 Australia
- 11.4.6 Singapore
- 11.4.7 Thailand
- 11.4.8 Malaysia
- 11.4.9 Indonesia
- 11.4.10 Philippines
- 11.4.11 Rest Of Asia Pacific
- 11.5 South America
- 11.5.1 Brazil
- 11.5.2 Rest Of South America
- 11.6 Middle East And Africa
- 11.6.1 South Africa
- 11.6.2 Rest Of Middle East And Africa
- 12 Global Dry Eye Syndrome Treatment Market, Company Landscape
- 12.1 Company Share Analysis: Global
- 12.2 Company Share Analysis: North America
- 12.3 Company Share Analysis: Europe
- 12.4 Company Share Analysis: Asia-pacific
- 13 Company Profiles
- 13.1 Allergan
- 13.1.1 Company Snapshot
- 13.1.2 Company Share Analysis
- 13.1.3 Revenue Analysis
- 13.1.4 Geographical Presence
- 13.1.5 Product Portfolio
- 13.1.6 Recent Developments
- 13.2 Alcon Inc
- 13.2.1 Company Snapshot
- 13.2.2 Company Share Analysis
- 13.2.3 Revenue Analysis
- 13.2.4 Geographical Presence
- 13.2.5 Product Portfolio
- 13.3 Bausch & Lomb Incorporated.
- 13.3.1 Company Snapshot
- 13.3.2 Company Share Analysis
- 13.3.3 Revenue Analysis
- 13.3.4 Geographical Presence
- 13.3.5 Product Portfolio
- 13.3.6 Recent Development
- 13.4 Novartis Ag
- 13.4.1 Company Overview
- 13.4.2 Company Share Analysis
- 13.4.3 Revenue Analysis
- 13.4.4 Geographical Presence
- 13.4.5 Product Portfolio
- 13.4.6 Recent Development
- 13.5 Johnson & Johnson Services, Inc.
- 13.5.1 Company Snapshot
- 13.5.2 Company Share Analysis
- 13.5.3 Revenue Analysis
- 13.5.4 Geographical Presence
- 13.5.5 Product Portfolio
- 13.5.6 Recent Developments
- 13.6 Akorn, Incorporated
- 13.6.1 Company Overview
- 13.6.2 Revenue Analysis
- 13.6.3 Geographical Presence
- 13.6.4 Product Portfolio
- 13.6.5 Recent Development
- 13.7 Horus Pharma
- 13.7.1 Company Overview
- 13.7.2 Geographical Presence
- 13.7.3 Product Portfolio
- 13.7.4 Recent Development
- 13.8 Mitotech, Sa
- 13.8.1 Company Overview
- 13.8.2 Geographical Presence
- 13.8.3 Portfolio
- 13.8.4 Recent Developments
- 13.9 Novaliq Gmbh
- 13.9.1 Company Overview
- 13.9.2 Geographical Presence
- 13.9.3 Product Portfolio
- 13.9.4 Recent Development
- 13.10 Prestige Consumer Healthcare, Inc.
- 13.10.1 Company Snapshot
- 13.10.2 Revenue Analysis
- 13.10.3 Geographical Presence
- 13.10.4 Product Portfolio
- 13.10.5 Recent Development
- 13.11 Santen Pharmaceutical Co., Ltd.
- 13.11.1 Company Overview
- 13.11.2 Revenue Analysis
- 13.11.3 Geographical Presence
- 13.11.4 Product Portfolio
- 13.11.5 Recent Development
- 13.12 Senju Pharmaceutical Co. Ltd.
- 13.12.1 Company Overview
- 13.12.2 Revenue Analysis
- 13.12.3 Geographical Presence
- 13.12.4 Product Portfolio
- 13.12.5 Recent Development
- 13.13 Similasan
- 13.13.1 Company Overview
- 13.13.2 Geographical Presence
- 13.13.3 Product Portfolio
- 13.13.4 Recent Development
- 13.14 Sun Pharmaceutical Industries Ltd.
- 13.14.1 Company Snapshot
- 13.14.2 Revenue Analysis
- 13.14.3 Geographical Presence
- 13.14.4 Product Portfolio
- 13.14.5 Recent Developments
- 13.15 Teva Pharmaceutical Industries Ltd.
- 13.15.1 Company Snapshot
- 13.15.2 Revenue Analysis
- 13.15.3 Geographical Presence
- 13.15.4 Product Portfolio
- 13.15.5 Recent Development
- 13.16 Visufarma
- 13.16.1 Company Overview
- 13.16.2 Geographical Presence
- 13.16.3 Product Portfolio
- 13.16.4 Recent Developments
- 14 Questionnaire
- 15 Related Reports
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook